On May 16, 2024, PATH Belgium marked a significant moment for global health dialogue and cooperation by convening an event during European Public Health Week in collaboration with the Embassy of Pakistan in Belgium and EUTOPIA titled Bridging Silos and Increasing Manufacturing Capacity through Science Diplomacy in LMICs. The panel discussion focused on bridging silos—for example, international regulations and national priorities—through the collaborative efforts of diplomacy, academia, civil society, and industry. Using science diplomacy to increase manufacturing capacity in low- and middle-income countries (LMICs) is crucial in the post-pandemic era, as the need for robust health systems and resilient supply chains worldwide cannot be overemphasized.
“The challenge in ramping up production is not just a financial constraint but involves a complex gridlock of knowledge, technology, and production rights. Yet, there is hope.”— Dr. Rolando Tomasini, PATH Director of Partnerships for Europe
Panel participants
The event featured a distinguished panel of leaders and experts, including Dr. Rolando Tomasini, PATH’s Director of Partnership Development for Europe; Her Excellency (H. E.) Amna Baloch, Pakistan's Ambassador to the European Union, Belgium, and Luxembourg; Nienke Buisman, Head of Unit for International Cooperation, EU’s Directorate-General for Research & Innovation; and Mr. Eric Piaget, Science Diplomacy Coordinator, EUTOPIA. The panel was moderated by Dr. Muhammad Adeel, Second Secretary, Embassy of Pakistan. The discussion produced a rich dialogue across academia, diplomacy, industry, and civil society.
Panel discussion with H. E. Ambassador Amna Baloch, Pakistan; Dr. Rolando Tomasini, PATH; Ms. Nienke Buisman, DG Research and Innovation EU; and Mr. Eric Piaget, EUTOPIA. Photo: PATH/Photographer: Ammani Ali Khan
Key discussions and outcomes
Amid rising geopolitical tensions and global health challenges, the discussions underscored the critical need for enhanced health infrastructure. The COVID-19 pandemic exposed vulnerabilities in global health supply chains, highlighting the need for increased manufacturing capacity within LMICs.
A key outcome from the panel was consensus on the importance of integrated efforts across sectors to mitigate future health crises. Emphasis was placed on community-led initiatives, which are essential for sustainable development and showcase the importance of local involvement in global health strategies.
PATH’s commitment
PATH’s involvement in this event reaffirms its commitment to advancing health sovereignty—the ability to effectively manage and sustain national health systems without undue dependence on external entities—and promoting health diplomacy, especially in LMICs. With extensive experience working closely with local communities, from research through implementation, PATH ensures sustainable interventions tailored to community needs. This dedication to people-centered care, combined with PATH’s expertise, fosters international cooperation and builds capacities crucial for health sovereignty in regions facing supply chain vulnerabilities.
Impact and future direction
As the global community navigates the dual challenges of pandemic recovery and efforts to bolster defenses against nontraditional security threats, such discourse provides a beacon of hope and direction. The insights from this event are set to influence policy decisions and strategic frameworks at both local and international levels. By bridging silos, encouraging interdisciplinary collaborations, and focusing on tangible outcomes, we can chart a course toward healthier and more sustainable development globally.